Navigation Links
BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
Date:10/24/2008

t our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates, that our projected burn rate may not be consistent with our expectations, that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (File No. 333-145638), Quarterly Reports on Form 10-Q, current reports on Form 8-K which identify important factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.

BCRXW


'/>"/>
SOURCE BioCryst Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. BioCryst to Present at UBS 2008 Global Life Sciences Conference
11. BioCryst to Present at the JMP Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics ... in metabolic disorders, announced today that it has filed ... Securities and Exchange Commission (SEC) relating to the proposed ... The number of shares to be offered and the ... determined. Citigroup and Cowen and Company will ...
(Date:8/27/2014)... 2014   MSC , a healthcare performance improvement ... the appointment of Mary Beth Loesch to ... of experience preparing companies for rapid growth and market ... President of Corporate Development and Healthcare. In that role, ... as well as corporate strategy and marketing. Previously, Loesch ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Chelating Agents Market ... About Chelating Agent A chelating agent is ... with metal ions, thereby forming a metal-ion complex. ... have on chemical processes, formulations, and the environment ...
(Date:8/27/2014)... 2014  A novel biomarker for rheumatoid arthritis ... identify early-stage disease, when treatment can often arrest ... new study in The Journal of Rheumatology. ... DGX ) and other institutions found that elevated ... antibody-serum testing, including rheumatoid factor (RF) and anti-citrullinated ...
Breaking Biology Technology:Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4
... more tech companies by offering tax credits, bringing the ... , ,Governor Jim Doyle on Monday added three biotechs, one ... state's Act 255 was passed last year to ... tax credits for investors. , ,This week's five companies were: ...
... Health and Human Services secretary and longtime Wisconsin governor, ... leaving his Cabinet post in January. , ,Thompson accepted ... Deloitte & Touche USA; law partner at Washington power ... of La Crosse-based Logistics Health Inc., a privately held ...
... Researchers led by James Dahlberg, a founder of Madison-based ... a super-small genetic element may play a critical role in ... by Dahlberg and collaborator Wayne Tam at the Joan and ... week in the Proceedings of the National Academy of Sciences ...
Cached Biology Technology:Tommy Thompson tackles the private sector in spades 2Third Wave co-founder shoots for small target in latest project 2
(Date:8/28/2014)... Energy production systems are good examples of complex ... like a networkincluding water for cooling, transport to ... management. Every step in the network chain is ... all mutually dependent. A team of UK-based scientists ... previously explored. The findings have been published in ...
(Date:8/28/2014)... release is available in German . ... are now built with the help of sophisticated assembly lines. ... are an important part of these assembly lines. In the ... in various work stages arranged in a precise spatial and ... of the line. , The creation of such an assembly ...
(Date:8/28/2014)... is needed to ensure safeguards are in place to ... PLOS ONE , researchers from Monash University, Stellenbosch University ... results from different studies - to look at the ... determine whether they actually protect biodiversity. , Dr ... area from human exploitation made common sense, however, up ...
Breaking Biology News(10 mins):Inter-dependent networks stress test 2Nanoscale assembly line 2Nanoscale assembly line 3Protected areas proven to protect biodiversity 2
... half-year old child, born deaf but with a cochlear implant that ... the child uttered during a testing session that involved play with ... the same age who had a cochlear implant 31 months earlier ... there with that noise and now -- Woo! Woo!" and "OK, ...
... of delivering chemotherapy to cancer patients without incurring side effects ... , The method, produced at the University of Bath, England, ... drug which are then implanted into the cancerous area in ... with body tissue, which means they would not be rejected ...
... a voracious, bullying exotic that has visited ecological havoc on ... , Since its introduction to Wisconsin waters sometime in the ... streams, clear cutting the underwater forests that are critical fish ... after another and scooping up fish eggs like so much ...
Cached Biology News:With cochlear implants, earlier use leads to better speech 2With cochlear implants, earlier use leads to better speech 3New device could cut chemotherapy deaths 2Study shows hope for ridding lakes of clawed invader 2Study shows hope for ridding lakes of clawed invader 3